FTO ameliorates doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via P53-P21/Nrf2 activation in a HuR-dependent m6A manner

  • 0Department of Cardiology, Second Hospital of Jilin University, Changchun, Jilin, 130041, China.

|

|

Summary

This summary is machine-generated.

Fat mass and obesity-associated protein (FTO) protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis. FTO upregulates P21/Nrf2, crucial for this protective effect, forming a feedback loop with HuR and P53.

Area Of Science

  • Biochemistry
  • Molecular Biology
  • Cardiology

Background

  • Doxorubicin (DOX) chemotherapy causes cardiotoxicity, limiting its use.
  • Ferroptosis, a type of cell death driven by lipid peroxidation, is a key mechanism in DOX-induced cardiotoxicity.
  • N6-methyladenosine (m6A) RNA modification influences DOX-induced ferroptosis, but its precise role is unclear.

Purpose Of The Study

  • To investigate the role of m6A modification, specifically the fat mass and obesity-associated protein (FTO), in DOX-induced cardiotoxicity.
  • To elucidate the underlying molecular mechanisms involving P21 and Nrf2 in FTO-mediated protection against ferroptosis.

Main Methods

  • Investigated FTO expression in DOX-treated mouse hearts and H9C2 cells.
  • Assessed the effects of FTO overexpression on cardiac function, cell viability, and ferroptosis markers.
  • Utilized P21 and Fer-1 (ferroptosis inhibitor) to evaluate their roles.
  • Examined the involvement of P53 and Human antigen R (HuR) using genetic manipulation and RNA immunoprecipitation assays.

Main Results

  • FTO downregulation correlated with DOX-induced cardiotoxicity.
  • FTO overexpression improved cardiac function and cell viability, inhibiting ferroptosis.
  • FTO upregulated P21 and activated Nrf2, mediating protection via P53-dependent or independent pathways.
  • HuR was essential for FTO's regulation of ferroptosis and the P53-P21/Nrf2 axis.
  • A positive feedback loop involving FTO, HuR, and P53-P21 was identified.

Conclusions

  • FTO inhibits DOX-induced ferroptosis and cardiotoxicity by activating the P21/Nrf2 pathway through m6A demethylation.
  • The FTO-HuR-P53-P21 axis represents a novel therapeutic target for mitigating DOX-induced cardiotoxicity.